Javascript must be enabled to continue!
Association between birthweight and Acute Lymphoblastic Leukemia in children, a systematic review
View through CrossRef
BackgroundBirthweight is normally determined by a range of genetic traits and exposures occurring within the intra-uterine environment. Some epidemiological studies have reported high birthweight as a risk factor of Acute lymphoblastic Leukemia (ALL). Other studies have however not demonstrated this relationship.ObjectivesThe objective of this review is to assess the association between birthweight and Acute Lymphoblastic Leukemia in children. Search methods We searched observational studies from Cochrane, MEDLINE, EMBASE, ISI Web of Science, BIOSIS, the allied and Complementary Medicine Database and National Research Register, ClinicalTrial.gov, WHO International Trials Registry Platform. Selection criteriaWe included case control and cohort studies assessing the association between birthweight and ALL in children. All particpants below the age of 18 years (children) with ALL were included in the analysis. The independent variable in this review was birthweight. Birthweight was categorised into two (2). Birthweight >4kg (experimental arm) and ≤ (control arm).Data collection and analysisTwo reviewers independently assessed identified studies through two stages of screening. First, titles and abstracts of all references identified through searches were screened and irrelevant studies were excluded. Also, full texts of potentially eligible studies were further assessed according to previously defined inclusion criteria. Studies that did not meet inclusion criteria were excluded and reasons for their exclusion were stated. All studies that met the inclusion criteria were included. Areas of disagreement were resolved by a third-party review. Two review authors double checked the studies independently.Main resultsOut of the 348 studies screened, 16 of them met the inclusion criteria. A total of 3650728 participant provided data for analysis in this review. These studies were published between 1987 and 2018. The age span of studies was similar across studies (roughly (0-18 years). The vast majority of ALL was diagnosed before 15 years. 14 of the included studies were case control studies and 2 of them were cohort studies. Figure 1 presents odd ratio estimates for effect of birthweight on ALL (≤ 4000g vs. > 4000g). There was a statistically significant positive relationship between high birthweight (birthweight > 4000g) and risk of ALL (16 studies, OR 0.81, 95% CI 0.77, 0.85). Authors' conclusionsOur study revealed a significant positive relationship between high birthweight and ALL. Several studies have demonstrated an association between factors such as: high pre-pregnancy weight and height; gestational age greater than 42 weeks; parity greater than and high birthweight. Therefore, public health programs and interventions aimed at reducing the incidence of these maternal factors can reduce the risk of high birthweight and lower the incidence of ALL.
Title: Association between birthweight and Acute Lymphoblastic Leukemia in children, a systematic review
Description:
BackgroundBirthweight is normally determined by a range of genetic traits and exposures occurring within the intra-uterine environment.
Some epidemiological studies have reported high birthweight as a risk factor of Acute lymphoblastic Leukemia (ALL).
Other studies have however not demonstrated this relationship.
ObjectivesThe objective of this review is to assess the association between birthweight and Acute Lymphoblastic Leukemia in children.
Search methods We searched observational studies from Cochrane, MEDLINE, EMBASE, ISI Web of Science, BIOSIS, the allied and Complementary Medicine Database and National Research Register, ClinicalTrial.
gov, WHO International Trials Registry Platform.
Selection criteriaWe included case control and cohort studies assessing the association between birthweight and ALL in children.
All particpants below the age of 18 years (children) with ALL were included in the analysis.
The independent variable in this review was birthweight.
Birthweight was categorised into two (2).
Birthweight >4kg (experimental arm) and ≤ (control arm).
Data collection and analysisTwo reviewers independently assessed identified studies through two stages of screening.
First, titles and abstracts of all references identified through searches were screened and irrelevant studies were excluded.
Also, full texts of potentially eligible studies were further assessed according to previously defined inclusion criteria.
Studies that did not meet inclusion criteria were excluded and reasons for their exclusion were stated.
All studies that met the inclusion criteria were included.
Areas of disagreement were resolved by a third-party review.
Two review authors double checked the studies independently.
Main resultsOut of the 348 studies screened, 16 of them met the inclusion criteria.
A total of 3650728 participant provided data for analysis in this review.
These studies were published between 1987 and 2018.
The age span of studies was similar across studies (roughly (0-18 years).
The vast majority of ALL was diagnosed before 15 years.
14 of the included studies were case control studies and 2 of them were cohort studies.
Figure 1 presents odd ratio estimates for effect of birthweight on ALL (≤ 4000g vs.
> 4000g).
There was a statistically significant positive relationship between high birthweight (birthweight > 4000g) and risk of ALL (16 studies, OR 0.
81, 95% CI 0.
77, 0.
85).
Authors' conclusionsOur study revealed a significant positive relationship between high birthweight and ALL.
Several studies have demonstrated an association between factors such as: high pre-pregnancy weight and height; gestational age greater than 42 weeks; parity greater than and high birthweight.
Therefore, public health programs and interventions aimed at reducing the incidence of these maternal factors can reduce the risk of high birthweight and lower the incidence of ALL.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Myosin-IIa Is Required for Leukemia Cell Extravasation and Its Inhibition Reduces Leukemia Dissemination and Prolongs Survival in a Mouse Model of Acute Lymphoblastic Leukemia
Myosin-IIa Is Required for Leukemia Cell Extravasation and Its Inhibition Reduces Leukemia Dissemination and Prolongs Survival in a Mouse Model of Acute Lymphoblastic Leukemia
Abstract
Background: Leukemia affects approximately 45,000 people each year in the USA with more than 20,000 fatalities. Many leukemia patients experience initial re...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Cytogenetic profile of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia in Northern Pakistan
Cytogenetic profile of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia in Northern Pakistan
Objective: To determine the frequencies of different cytogenetic abnormalities in patients of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia in Northern Pakistan.
Methods...
CircNR3C1 promotes acute lymphoblastic leukemia progression via the MSI2/ENO1/RPS3 axis
CircNR3C1 promotes acute lymphoblastic leukemia progression via the MSI2/ENO1/RPS3 axis
Abstract
Acute lymphoblastic leukemia is a hematological malignancy characterized by the uncontrolled proliferation of immature lymphoid cells, but the role of ci...
STAT3 Mutations in Large Granular Lymphocytic Leukemia
STAT3 Mutations in Large Granular Lymphocytic Leukemia
Abstract
Abstract 1606
Introduction:
Large granular lymphocytic leukemia (LGL leukemia) is a rare lymphoprolifera...
PENGARUH KEMOTERAPI TERHADAP PROFIL HEMATOLOGI PADA PENDERITA LEUKEMIA LIMFOBLASTIK AKUT
PENGARUH KEMOTERAPI TERHADAP PROFIL HEMATOLOGI PADA PENDERITA LEUKEMIA LIMFOBLASTIK AKUT
Abstract Leukemia atau lebih dikenal kanker pada darah atau sumsum tulang merupakan pertumbuhan sel-sel abnormal tidak terkontrol (sel neoplasma) yang berasal dari hasil mutasi sel...
Nature Products Enhance NKG2D Ligands Expression of CD123+CD34+CD38− Leukemia Stem Cells for Stimulating Cytotoxicity of NKG2D+ Cells to Themselves
Nature Products Enhance NKG2D Ligands Expression of CD123+CD34+CD38− Leukemia Stem Cells for Stimulating Cytotoxicity of NKG2D+ Cells to Themselves
Abstract
CD123+CD34+CD38− leukemia cells regarded as leukemia stem cells, not only refractory to chemotherapeutics but also resistant to immune response such as cyto...

